Yuka Kasamatsu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Locally Advanced

Endometrial Cancer

Epithelial Mesenchymal Transition

Neoadjuvant Chemotherapy

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of gynecologic oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Ana Oaknin, Sharad A Ghamande, Yuka Kasamatsu, Marta Gil-Martin, Juan Francisco Grau Bejar, Carmen Garcia-Duran, Masashi Sato, Abdul Siddiqui, Surendra Pal Chaudhary, Yulia Vugmeyster, Kosei Hasegawa
Phase 1 trial of first-line bintrafusp alfa in patients with locally advanced or persistent/recurrent/metastatic cervical cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ana Oaknin, Sharad A Ghamande, Yuka Kasamatsu, Marta Gil-Martin, Juan Francisco Grau Bejar, Carmen Garcia-Duran, Masashi Sato, Abdul Siddiqui, Surendra Pal Chaudhary, Yulia Vugmeyster, Kosei Hasegawa
Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (5) (2024)
Ana Oaknin, Sharad A Ghamande, Yuka Kasamatsu, Marta Gil-Martin, Juan Francisco Grau Bejar, Carmen Garcia-Duran, Masashi Sato, Abdul Siddiqui, Surendra Pal Chaudhary, Yulia Vugmeyster, Kosei Hasegawa
Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (5) (2024)
Kensuke Hori, Shin Nishio, Kimio Ushijma, Yuka Kasamatsu, Asumi Okumura, Kazuhiro Takehara, Kimihiko Ito
A phase II, open-labeled, single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine endometrial cancer treatment: a KCOG-G1303, DOENCA trial. Journal of gynecologic oncology 32 (4) (2021)